Polyunsaturated phosphatidylcholine lowers collagen deposition in a rat model of corrosive esophageal burn.
Esophageal strictures are characterized by excess deposition of collagen in the esophageal wall. Polyunsaturated phosphatidyl-choline (PPC) stimulates collagen breakdown in experimental models of liver cirrhosis and colitis. This study was done in order to investigate the therapeutical effect of PPC in preventing esophageal strictures due to alkali-induced esophageal burns in rats. Fifty-five albino rats were divided into four groups as follows: control group (Group A, 10 rats), rats with sham operation and treated with saline (Group B, 15 rats), rats with esophageal burns only (Group C, 15 rats), and PPC-fed rats with esophageal burns (Group D, 15 rats). A standard esophageal burn was produced as described by Gehanno. PPC was administered orally to Group D rats in doses of 100 mg/day for four weeks. All animals were sacrificed on the 28th day of the experiment. Hydroxyproline levels in esophageal tissue was determined in each rat, and histopathologic evaluation was performed for each group. Hydroxyproline levels were significantly lower in the PPC-fed rats than in the rats with pure esophageal burns (p < 0.001). Histopathologically, collagen deposition in the submucosa and tunica muscularis was lower in Group D rats (PPC-fed rats with esophageal burn) than Group C rats (pure esophageal burn) (p < 0.05). As a result of our study, we concluded that PPC has an ameliorating effect on stricture formation after alkali-induced corrosive esophageal burns in rats.
Demirbilek
S
S
Department of Pediatric Surgery, Harran University Faculty of Medicine, Sanliurfa, Turkey. sdemirbilek@ixir.com
Aydin
G
G
Yücesan
S
S
Vural
H
H
Bitiren
M
M
D000818:Animals; D002057:Burns, Chemical / Q000150:complications* / Q000378:metabolism; D003094:Collagen / Q000378:metabolism*; D004195:Disease Models, Animal; D004940:Esophageal Stenosis / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control*; D004947:Esophagus / Q000378:metabolism; D005260:Female; D006909:Hydroxyproline / Q000378:metabolism; D010713:Phosphatidylcholines / Q000627:therapeutic use*; D051381:Rats
D010713:Phosphatidylcholines; C029449:polyene phosphatidylcholine; D003094:Collagen; D006909:Hydroxyproline